Ablynx NV

Complix

This company develops protein therapeutics based on its alphabody technology to treat cancer, viral diseases and autoimmune conditions for the pharmaceutical industry.

ArgenX

This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.

ABL Bio

The company develops bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases for pharmaceutical partners and clinical research applications.

Affibody AB

This biotechnology company develops biopharmaceuticals and radioligand therapies for patients with cancer and inflammatory diseases by using its proprietary protein technology platforms.

AbCellera Biologics

The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.

Precirix

This biotechnology company develops precision radiopharmaceuticals using camelid single-domain antibodies to treat patients with various types of cancer.

Abilita Therapeutics

This biotechnology company develops membrane protein stabilization technologies and antibody therapeutics for pharmaceutical and biotechnology partners targeting challenging drug targets.

Abgentis

This company develops broad-spectrum antibacterial drugs for pharmaceutical firms to treat acute, chronic, and drug-resistant infections.